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ABSTRACT 
 
Utilization of a Metabolic Syndrome Index in Evaluating the Life in BALANCE 
Lifestyle Intervention for Prevention of Type 2 Diabetes among  
Urban American Indians and Alaska Natives 
 
by 
 
Hongbin Jin 
 
Dr. Michelle Chino, Examination Committee Chair 
Associate Professor of Environmental and Occupational Health  
School of Community Health Sciences 
University of Nevada, Las Vegas 
 
Background: A myriad of diabetes prevention programs modeled on the Diabetes 
Prevention Program (DPP) are carried out worldwide to fight against the current diabetes 
pandemic. The percentage of weight reduction is a widely used indicator to evaluate 
diabetes prevention programs. However, weight change alone may not fully reflect the 
efficacy of lifestyle intervention. A metabolic syndrome index is a promising novel scale 
for evaluation of diabetes prevention programs because it is a systematic, comprehensive, 
and stable indicator that reflects the metabolic risk reduction for diabetes and its 
complications at multiple levels and dimensions. 
Methods: A total of 22 overweight and obese AI/ANs (age, 39.6 ± 10.4 years; BMI, 
34.1± 6.3 kg/m
2
) at increased risk for developing type 2 diabetes residing in Las Vegas 
participated in the LIB program between April, 2010 and December, 2011. Metabolic 
syndrome was defined according to the American Heart Association and the National 
Heart, Lung, and Blood Institute criteria. Clinical measures were collected at three 
different points in time before and after the completion of the LIB lifestyle core 
curriculum and the end of post-program follow-up.  
iv 
 
Results: Only 12 of the 22 participants completed the whole LIB program. Among the 
five metabolic syndrome components, only waist circumference demonstrated a 
significant correlation with weight. After a mean follow-up interval of 10.4 months, the 
metabolic syndrome index was reduced by 11% at the completion of the LIB program. 
The study population demonstrated significant decreased waist circumference and 
elevated HDL cholesterol. Triglycerides manifested the highest percentage change 
without statistical significance. No significant change was observed in blood pressure and 
fasting blood glucose. 
Conclusions: These findings imply that the application of a metabolic syndrome index 
provides more detailed information than weight in evaluating diabetes prevention 
programs by analyzing pre-post changes in multiple diabetes markers, particularly when 
the target population has normal to slightly elevated BMI. Additionally, the changes in 
metabolic syndrome components outline the characteristics of diabetes prevention 
programs, showing great potential for helping public health professionals to individualize 
and optimize program curriculums for different target populations. Promotion of 
metabolic syndrome index in diabetes research will establish a unified criterion in 
evaluating diabetes prevention programs and facilitate efficacy comparison among 
different programs.  
Key word: Diabetes; Metabolic syndrome; Prevention; Evaluation 
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CHAPTER 1 
INTRODUCTION 
 
Percentage change from participants’ starting weight is a widely used indicator to 
evaluate the efficacy of diabetes prevention programs (Ali, Echouffo-Tcheugui, & 
Williamson, 2012). Weight loss is a direct consequence of diet modification and exercise 
which are the two most common constructs in diabetes prevention programs. Yet, weight 
change alone may not fully reflect the efficacy of lifestyle intervention in terms of 
improving prediabetes conditions and reducing the risk of developing type 2 diabetes and 
its complications. Additionally, the accuracy and reliability of weight change is 
insufficient, since it can be affected by many confounding factors. 
Metabolic syndrome, which is associated with central obesity and insulin 
resistance, has been demonstrated as a reliable predictor of type 2 diabetes in many 
epidemiological studies (Lorenzo, Okoloise, Williams, Stern, & Haffner, 2003; Wilson, 
D’Agostino, Parise, Sullivan, & Meigs,  2005; Mannucci et al., 2008; Wassink, Van Der 
Graaf, Soedamah-Muthu, Spiering, & Visseren, 2008). The presence of metabolic 
syndrome accounts for approximately half of the population attributable risk for diabetes 
(Wilson et al., 2005). Previous research studies have shown that, independent of weight 
loss, symptoms of metabolic syndrome can be reduced by lifestyle intervention (Christ, 
Iannello, Iannello, & Grimm, 2004; Okura et al., 2007; Muzio, Mondazzi, Harris, 
Sommariva, & Branchi, 2007; Meckling & Sherfey, 2007; Rector et al., 2007). However, 
the extent of improvement in each component of metabolic syndrome varied from project 
to project. A metabolic syndrome index is a multivariate parameter incorporating the 
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components of metabolic syndrome, which systematically, comprehensively and stably 
reflects the metabolic risk for diabetes and its complications.  
From the perspective of epidemiology, population attributable risk is employed to 
describe risk reduction for a disease or an unhealthy condition objectively. However, a 
reduction in incidence cannot be measured without a control group. In this study, we 
propose to use a new concept – metabolic risk – in describing and quantifying the risk 
reduction caused by diabetes prevention programs. First, type 2 diabetes is a chronic 
metabolic disease. Research on metabolic risk factors for type 2 diabetes and its 
complications has greatly advanced in past decades and metabolic syndrome has been 
widely accepted as a predictor for type 2 diabetes and its complications. Second, 
metabolic risk for diabetes and its complications is generally attributable to 
environmental and behavioral factors. In other words, this type of risk, to some extent is 
separate from genetic risk and can be reduced by lifestyle intervention. The risk reduction 
in terms of the improvement in health status can be measured and quantified by a 
metabolic syndrome index. Additionally, adoption of metabolic risk is convenient for 
public health professionals because it is a direct reflection of the efficacy of diabetes 
prevention intervention. 
To improve the evaluation methods for diabetes prevention programs to 
accurately and objectively reflect the metabolic risk reduction of developing type 2 
diabetes and its complications, the metabolic syndrome index should be promoted as a 
preferred outcome indicator over weight loss for diabetes prevention programs. 
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Purpose of the Study 
The purpose of this study is to utilize a novel indicator – the metabolic syndrome 
index – to evaluate the Life in BALANCE (LIB) lifestyle intervention for prevention of 
type 2 diabetes among urban American Indians and Alaska Natives (AI/AN) residing in 
Las Vegas. This study will promote the improvement of evaluation methods for diabetes 
prevention programs by creating a new scale to measure the magnitude of metabolic risk 
reduction for developing type 2 diabetes and its complications after intensive lifestyle 
intervention.  
 
Research Question 
Will the metabolic syndrome index be useful in evaluating the Life in BALANCE 
lifestyle intervention for prevention of type 2 diabetes among urban AI/ANs residing in 
Las Vegas?  
Answering this question requires incorporating the following procedures in the 
study plan: 1) assess the change of the five components of metabolic syndrome and 
weight across the LIB program, 2) analyze the correlation between the five metabolic 
syndrome components and weight, and 3) assess the change of the metabolic syndrome 
index across the LIB program and compare with weight loss.  
 
Hypotheses 
Hypothesis1 
H0: There is no significant difference between pre- and post-intervention waist 
circumferences among urban AI/ANs residing in Las Vegas. 
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HA: There is significant difference between pre- and post-intervention waist 
circumferences among urban AI/ANs residing in Las Vegas. 
HA1: Post-intervention waist circumference is significantly less than pre-intervention 
waist circumference among urban AI/ANs residing in Las Vegas. 
Note: This hypothesis will be repeated for systolic blood pressure, diastolic blood 
pressure, triglycerides, HDL cholesterol, and fasting blood glucose. 
Rationale: Previous research studies have indicated that the five components of 
metabolic syndrome respond differently to different lifestyle intervention designs (Christ 
et al., 2004; Okura et al., 2007; Muzio et al., 2007; Meckling & Sherfey, 2007; Rector et 
al., 2007). To a great extent, the design of a lifestyle intervention curriculum 
predetermines its efficacy. Therefore, the first step of this study is to determine whether 
the LIB program has reduced the symptoms of metabolic syndrome and the magnitude of 
the reductions.  
Every program has its strengths and weaknesses, and not every component will 
necessarily demonstrate a statistically significant improvement. However, it is good to 
know what a program’s strengths so that health professionals can choose the most 
effective program. By using a metabolic syndrome index, the magnitude of the change in 
the five components can serve as a program’s “resume” by outlining the effect of each 
characteristic of a program. 
Hypothesis 2 
H0: There is no significant correlation between waist circumference and weight among 
urban AI/ANs residing in Las Vegas. 
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HA: There is significant correlation between waist circumference and weight among 
urban AI/ANs residing in Las Vegas. 
Note: This hypothesis will be repeated for systolic blood pressure, diastolic blood 
pressure, triglycerides, HDL cholesterol, and fasting blood glucose. 
Rationale: Theoretically, obesity is connected with the five components of 
metabolic syndrome directly or indirectly; however, the strength of their relationships 
varies. If a metabolic syndrome component is not correlated with weight, the risk for 
diabetes and its complications caused by the component cannot be fully revealed by 
weight. 
Many research studies have indicated that waist circumference is highly 
correlated with body weight, but central obesity characterized by excess accumulation of 
abdominal fat is a stronger predictor for diabetes (Feller, Boeing, & Pischon, 2010). If the 
remaining four metabolic syndrome components are not significantly correlated with 
weight, the risk reduction caused by them cannot be reflected by weight loss alone. This 
would support the idea that a metabolic syndrome index is more systematic than weight 
loss in evaluating diabetes prevention programs. The hypothetical relationship between 
weight and metabolic syndrome is illustrated in Figure 1. 
Hypothesis 3 
H0: There is no significant difference between pre- and post-intervention metabolic 
syndrome indexes among urban AI/ANs residing in Las Vegas. 
HA: There is significant difference between pre- and post-intervention metabolic 
syndrome indexes among urban AI/ANs residing in Las Vegas. 
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HA1: Post-intervention metabolic syndrome index is significantly less than pre-
intervention metabolic syndrome index among urban AI/ANs residing in Las Vegas. 
Rationale: The method to calculate the metabolic syndrome index will be 
presented in detail in the methods section. This step is to test whether the metabolic 
syndrome index has been decreased through the LIB lifestyle intervention. The 
magnitude of reduction (percentage change) represents the amount of metabolic risk for 
diabetes and its complications that has been reduced.  
 
      
 
 
Figure 1. Hypothetical Relationship between Weight and Metabolic Syndrome in Reflecting the 
Real Risk for Diabetes and Its Complications 
 
Significance of the Study 
This study will establish a better indicator than weight loss for evaluating diabetes 
prevention program outcomes, which systematically, comprehensively and stably 
quantifies the risk reduction for diabetes and its complications caused by lifestyle 
intervention. Metabolic syndrome reflects more facets of risk for diabetes and its 
complications than weight loss and a metabolic syndrome index incorporates this cluster 
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of metabolic risk factors and integrates them into one scale. Lastly, by applying the 
metabolic syndrome index, a program “resume” will be created to facilitate program-to-
program comparisons, which will greatly enhance the researchers’ ability to select an 
intervention program better suited to their study population with increased efficacy. 
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
 
Type 2 Diabetes 
Diabetes is a global public health crisis affecting all socioeconomic classes and all 
races (Caprio et al, 2008). Diabetes is a common, disabling, and deadly disease with an 
increasing health and financial burden on individuals and countries. According to the 
Center for Disease Control and Prevention (CDC, 2011), in 2010 approximately 8.3% of 
the U.S. population (25.8 million) had diabetes and 35% of U.S. adults aged 20 years or 
older (79 million) had prediabetes, a condition in which blood glucose levels are higher 
than normal but not yet meet the diagnostic criteria for diabetes (ADA, 2012). Diabetes is 
the ninth leading cause of death worldwide (WHO, 2008) and the seventh leading cause 
of death in the United States (CDC, 2009).  
The risk of death in people with diabetes is about twice as that in people without 
diabetes (CDC, 2011), which can be largely attributed to the diabetes-related 
complications. In addition to the risk of death, long-term complications such as heart 
disease, stroke, hypertension, diabetic retinopathy, and amputation drastically increase 
medical expenses and severely undermine the life quality of diabetes patients. A recent 
estimate reported that the U.S. national economic burden of prediabetes and diabetes 
reached $218 billion in 2007 (Dall et al., 2010). 
Type 2 diabetes is a chronic disease characterized by increased blood glucose 
levels that result from either insufficient insulin production or insulin resistance, a 
condition where cells ignore the insulin. It is a multifactorial disease caused by both 
genetic factors as well as non-genetic factors that result from individual behavior and 
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environment (Report of the Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus, 2003). For example, some specific genes are associated with glucose 
homeostasis and regulate the magnitude of the effects of lifestyle choices such as 
physical activity (Lakka et al., 2004).  
Minorities such as American Indian/Alaska Natives (AI/AN) suffer a 
disproportionately high burden of diabetes (Mokdad, Bowman, Enqelqau, & Vinicor, 
1998). AI/ANs have the highest age-adjusted prevalence and incidence of diabetes among 
all U.S. racial and ethnic groups in spite of the fact that numerous programs funded by 
U.S. government have been conducted in AI/AN communities to prevent and treat 
diabetes since 1997 (CDC, 2003). The causes of astoundingly high prevalence rates of 
diabetes among AI/ANs and other high prevalence populations remain unclear, but the 
evident race/ethnicity disparities may be accounted for by genetic predisposition to some 
extent. Studies rooted in Neel’s “thrifty genotype” hypothesis advocate that diabetes has 
a strong genetic basis (Neel, 1962 & 1999; Ritenbaugh & Goodby, 1989). Previous 
genetic research has shown that several genes such as maturity onset diabetes of the 
young (MODY) genes and atypical diabetes mellitus (ADM) genes significantly 
contribute to some rare forms of diabetes (Benyshek, 2001). However, recent research 
suggests that type 2 diabetes has multiple and complex etiologies and genetic factors do 
not play a dominant role in this etiological puzzle. Substantial evidence indicated that 
maternal glucose during pregnancy is significantly associated with abnormal glucose 
intolerance in adulthood. Both nutritional deficits and surplus during prenatal and 
perinatal periods lead to increased adipose deposition later in life and raise the risk for 
type 2 diabetes (Benyshek, 2007). On the other hand, various behavioral and 
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environmental risk factors play important roles in the development of diabetes as well. 
Healthy diet and regular physical activity have been linked with a reduced risk of 
developing type 2 diabetes in terms of reducing body adiposity, improving insulin 
resistance, and ameliorating glucose tolerance (Ross et al., 2000; Kelley & Goodpaster, 
2001).  
Type 2 diabetes is shaped by a multitude of factors that include genetics, 
developmental factors during key stages of early life, lifestyle choices, as well as 
socioeconomic barriers. From the perspective of chronic disease epidemiology, a group 
of risk factors associated with type 2 diabetes are aging, overweight or obesity, high 
blood pressure, high triglyceride level, low HDL cholesterol level, sedentary or inactive 
lifestyle, previous positive impaired fasting blood glucose or impaired glucose tolerance, 
high-fat diet, family history, ethnicity and race, and gestational diabetes or giving birth to 
a low birth weight (< 2.5 kg) or high birth weight (> 4.0 kg) baby (NDEP, 2012). 
 
The Diabetes Prevention Program 
Recently, the most inspiring achievement in diabetes research was the Diabetes 
Prevention Program (DPP, 2002) funded by the National Institute of Diabetes and 
Digestive and Kidney Diseases, which demonstrated that lifestyle changes and metformin 
treatment both reduced the incidence of diabetes in high risk population, but the lifestyle 
intervention, in particular was more effective in preventing or delaying the development 
of diabetes (Knowler et al., 2007).  
A myriad of diabetes prevention programs modeled on the DPP are carried out 
worldwide to fight against the diabetes pandemic (WHO, 2012). These programs are 
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individualized for specific target populations and optimized for the best use of resources 
and budgets. Even though most of the programs are translational projects sharing classic 
constructs such as lifestyle intervention, diet modification and exercise, the reported 
efficacy of these programs differed dramatically due to different program designs and 
evaluation methods (Ali et al., 2012). 
 
Weight Loss 
Percentage change from participants’ starting weight is a widely used indicator to 
assess and evaluate the efficacy of diabetes prevention programs (Ali et al., 2012). The 
DPP proclaimed that diabetes can be delayed or averted through systematic and intensive 
lifestyle intervention (Knowler et al., 2007). A follow-up study concluded that 
intervention to reduce diabetes should primarily target weight reduction (Hamman et al., 
2006). However, even when weight is regained after the DPP, the risk reduction for 
diabetes resulting from lifestyle intervention can persist for at least 10 years (Knowler et 
al., 2009).  
There are many reasons why weight loss is prevailing in diabetes prevention 
programs as the main outcome. First, weight loss is an easy and affordable parameter to 
be measured repeatedly across the whole program. Second, weight loss is a predictable 
consequence of diet modification and exercise which are the two most common 
constructs in diabetes prevention programs, and which generally manifests dose-response 
relationship. Furthermore, limited by the nature of their study designs and ethical issues, 
most diabetes prevention programs are not allowed to include a control group so that they 
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fail to measure the “real” risk reduction – the reduced diabetes incidence, which is more 
common in long-term cohort or experimental studies.  
Overall, weight loss seems to be a rational alternative and has been adopted by 
many programs. However, weight loss alone may not fully reflect the efficacy of diabetes 
prevention programs in terms of improving prediabetes conditions and reducing the risk 
of developing type 2 diabetes and its complications. The Finnish Diabetes Prevention 
Study demonstrated that the risk of diabetes was reduced 58% through lifestyle 
intervention after a 3-year follow-up in spite of minimal weight loss. More important, the 
authors emphasized that exercising 4 hours per week reduced the risk of diabetes in 
participants without weight loss (Tuomilehto et al., 2001). Many research studies have 
confirmed that beneficial changes in type 2 diabetes incidence can be achieved 
independently of weight loss (Pan et al., 1997; Ramachandran et al., 2006). Furthermore, 
the accuracy and reliability of weight change is problematic. Loss of muscle and bone 
mass instead of fat loss are likely to happen due to unhealthy diet and exercise plans. 
Stress caused by dramatic lifestyle change without sufficient family support may also 
contribute to weight loss. Additionally, weight measurement can be affected by 
confounding factors such as food and fluid intake prior to the measurement.  
 
Metabolic Syndrome 
Metabolic syndrome was first recognized by Reaven in 1988 (Reaven, 1988) as a 
cluster of risk factors such as dyslipidemia, hypertension, and hyperglycemia for 
cardiovascular disease. Later, insulin resistance was introduced into metabolic syndrome 
which drastically expanded its application in diabetes research. Findings from the 
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Framingham Heart study showed that metabolic syndrome predicted 25% of all new 
cases of cardiovascular disease (Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004). The 
“common soil” hypothesis suggested that type 2 diabetes and cardiovascular diseases 
share pathogenetic pathways (Stern, 1995). It has been widely accepted that metabolic 
syndrome is a constellation of metabolic risk factors in a person which contribute to both 
atherosclerotic cardiovascular disease and type 2 diabetes (Grundy et al., 2004; Alberti, 
Zimmet & Shaw, 2005; Grundy et al., 2005). Several organizations such as the World 
Health Organization, the International Diabetes Foundation, and the American Heart 
Association have proposed diagnostic criteria for metabolic syndrome in the efforts to 
promote its clinical practice in predicting the risk of cardiovascular disease and type 2 
diabetes (Alberti & Zimmet, 1998; Balkau & Charles, 1999; Grundy et al., 2004; Alberti 
et al., 2005; Grundy et al., 2005). Although there is no consensus criteria for metabolic 
syndrome, hyperglycemia, hypertension, obesity, and dyslipidemia have been accepted as 
major components for this multiplex risk syndrome. These components connect with each 
other and constitute a network to comprehensively measure the risk for diabetes and its 
complications. Nonetheless, they are not inter-replaceable due to their independent roles 
in human metabolism. 
Components of Metabolic Syndrome 
Hyperglycemia (fasting blood glucose): Current research suggested that insulin 
resistance is the primary cause of metabolic syndrome (Deen, 2004), although the 
temporal sequence of insulin resistance and obesity is still unknown. However, insulin 
resistance will change the metabolism of carbohydrates and lipids (Shaw et al., 2005). 
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Dyslipidemia (triglycerides and HDL cholesterol): Hyperinsulinemia resulting 
from insulin resistance will lead to increased triglycerides and decreased HDL cholesterol 
(Shaw et al., 2005), which are common symptoms in type 2 diabetes patients (Moller & 
Kaufman, 2005; Alberti et al., 2006).  
Hypertension (high systolic blood pressure and/or diastolic blood pressure): 
Hypertension has been strongly associated with both glucose intolerance and obesity. 
One research study suggested that hypertension is caused by hyperactive sympathetic 
nervous systems as a result of hyperglycemia (Shaw, Hall, & Williams, 2005). 
Obesity (waist circumference): Obesity has been associated with insulin 
resistance, dyslipidemia and hypertension (Grundy et al., 2004) and contributes to the 
development of cardiovascular disease. Central obesity, in particular, strongly correlates 
with metabolic risk factors (Grundy et al., 2004; Wassink et al., 2008). Waist 
circumference is considered as an easy way to determine central obesity (Alberti et al., 
2005).  
Despite the fact that different criteria were adopted in epidemiological research, 
metabolic syndrome has been recognized as a precursor of cardiovascular disease and 
type 2 diabetes (Lorenzo et al., 2003; Wilson et al., 2005). Furthermore, several cohort 
studies have indicated that metabolic syndrome is a stronger predictor of type 2 diabetes 
than that of cardiovascular disease (Lorenzo et al., 2003; Wilson et al., 2005; Ford, Li, & 
Sattar, 2008), which accounts for approximately one fourth and half of the population-
attributable risk for cardiovascular disease and diabetes respectively (Wilson et al., 2005). 
However, in light of the common pathophysiological pathways, cardiovascular disease 
becomes the primary complication of type 2 diabetes. In 2004, heart disease and stroke 
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were the top two complications of diabetes which accounted for 84% of deaths related to 
diabetes altogether (CDC, 2011).  
To calculate the metabolic syndrome index, clinical cutoff values are required in 
this process. The criteria of clinical diagnosis of metabolic syndrome proposed by 
different organization are summarized in Appendix 1. In this study, the cutoff values 
from the American Heart Association (AHA) and the National Heart, Lung, and Blood 
Institute (NHLBI) criteria of metabolic syndrome were adopted. The criteria proposed by 
the European Group for Study of Insulin Resistance (EGIR) and American Association of 
Clinical Endocrinologists (AACE) were excluded from this study because they do not 
take patients with diabetes into account, which limits their application in diabetes 
prevention programs. The International Diabetes Foundation (IDF) criteria and 
AHA/NHLBI criteria are the updated versions for the World Health Organization (WHO) 
criteria and the National Cholesterol Education Program’s Adult Treatment Panel III 
Report (NCEP) criteria respectively. The advantage of the IDF criteria is that it includes 
various waist circumference cutoff values which are specific to different ethnic groups. 
However, it doesn’t provide reference values for AI/ANs and many research studies 
reported that the criteria of the NCEP are more effective in identifying subjects at risk for 
diabetes than the IDF criteria. Updates to the AHA/NHLBI criteria include lowering the 
fasting blood glucose threshold to 100 mg/dL, which is consistent with the prediabetes 
definition proposed by the American Diabetes Association. 
Metabolic syndrome is an effective and efficient indicator in predicting the risk 
for developing diabetes and its complications. The question is whether metabolic 
syndrome is a sensitive and dynamic parameter in response to the risk reduction caused 
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by lifestyle intervention. A secondary analysis of the DPP found that both lifestyle 
intervention and metformin therapy reduced the development of the metabolic syndrome 
(Orchard, 2005). Further investigations by several studies found that the adoption of 
healthy diet and regular exercise, either alone or in combination can improve the 
components of the metabolic syndrome in some way (Christ et al., 2004; Okura et al., 
2007; Muzio et al, 2007; Meckling & Sherfey, 2007; Rector et al., 2007). However, the 
improvement in the components of metabolic syndrome varied with different levels of 
intensity and combinations of interventions.  
 
Rationale for the Metabolic Syndrome Index 
The DPP provided a template for future diabetes prevention programs in 
establishing basic constructs and timeframes. However, different principles and study 
designs have been employed to individualize and optimize these programs. The DPP is a 
long-term experimental study (clinical trial) which allows the real risk for diabetes in 
terms of the incidence of diabetes to be observed. The highly successful study showed 
that a minimum of 7% weight loss or weight maintenance and a minimum of 150 minutes 
physical activity per week resulted in a 58% reduction in the incidence rate of diabetes 
(DPP, 2002). Unfortunately, most of the translational studies are short-term health 
promotion programs, which fail to measure the real risk reduction without controls. Many 
translational studies adopt the percentage of weight reduction as a targeted outcome in 
order to estimate the real risk reduction through comparison with the DPP. However, 
weight loss alone may not be able to reflect the effectiveness of these programs in terms 
of ignoring the characteristics in different program designs. For example, the percentage 
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of weight loss may be different between a program designed for individuals suffering 
from obesity and that of a program designed for individuals suffering from severe insulin 
resistance.  
Lifestyle intervention for diabetes prevention programs is a multidimensional 
process with a series of health promotion strategies at multiple levels. The complexity of 
diabetes prevention programs necessitates a comprehensive and integrated indicator to 
evaluate their efficacy. Unlike the weight loss, the components of metabolic syndrome 
provide a multivariate parameter which covers more aspects of risk reduction caused by 
lifestyle intervention. A metabolic syndrome index is a systematic and comprehensive 
indicator that can be used to evaluate the efficacy of diabetes prevention programs 
because it measures risk reduction for diabetes and its complications at multiple levels 
and dimensions. A reduction in the metabolic syndrome index reflects the risk reduction 
for diabetes and its complications resulting from a diabetes prevention program, which 
makes program-to-program comparison possible. In addition, the five components of the 
metabolic syndrome index, to some extent represent different aspects of the risk for 
diabetes and its complications. The magnitude of change in the five components outlines 
the strengths and weaknesses of a program, which can serve as a useful reference for 
researchers to choose the best program for specific populations. 
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CHAPTER 3 
METHODS 
 
Calculation Method for the Metabolic Syndrome Index 
A metabolic syndrome index is a five-point scale that assigns one point to each of 
the five metabolic syndrome components - waist circumference, blood pressure, 
triglycerides, high-density lipoprotein (HDL) cholesterol, and fasting blood glucose. The 
clinical cutoff values for this study were those from the metabolic syndrome criteria 
proposed by the American Heart Association (AHA) and the National Heart, Lung, and 
Blood Institute (NHLBI) in 2005 (Grundy et al., 2005).  
The five components are assumed to be equally important for diabetes and its 
complications because each component is assigned one point only. The component 
equality is assured by the AHA/NHLBI definition, which is defined as the presence of 
any three or more of the following five components - central obesity (waist 
circumference > 102 cm for men, > 88 cm for women), elevated triglycerides (≥ 150 
mg/dL), hypertension (systolic BP ≥ 130 mmHg, and/or diastolic BP ≥ 85 mmHg), raised 
fasting blood glucose (≥ 100 mg/dL), and reduced HDL cholesterol (< 40 mg/dL for men, 
< 50 mg/dL for women). By adjusting the clinical cutoff values, a balance is reached 
among the five components, guaranteeing that they contribute equally to a metabolic 
syndrome diagnosis.  
One point will be counted if a component meets the clinical criteria above and a 
total score will be calculated as the metabolic syndrome index for each participant. A 
range from zero to five quantifies the metabolic risk for diabetes and its complications 
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which can be reduced by lifestyle intervention. A metabolic syndrome index should be 
measured at least twice (before and after intervention) in order to calculate the magnitude 
of the risk reduction potentially resulting from the intervention.   
 
Data Collection and Treatment 
The Life in BALANCE (LIB) project, conducted by the University of Nevada, 
Las Vegas, was a community-based participatory research project to pilot a translational 
study that modeled the Diabetes Prevention Program (DPP) intensive lifestyle coaching 
intervention in urban American Indian/Alaska Native (AI/AN) population. AI/ANs suffer 
a disproportionately high burden of type 2 diabetes and the incidence has been escalating 
at an alarming rate since the early 1960s (Valway et al., 1993). Urban AI/AN populations, 
which account for 60% of AI/ANs, may confront a worse scenario because they are 
affected more by modernized lifestyles and benefit less from the health services provided 
by tribal reservations and the Indian Health Service (IHS). The LIB program provided an 
opportunity to study the full extent of the problem of diabetes in this underserved 
population and utilize a metabolic syndrome index in evaluating the LIB pilot study in 
urban AI/AN population. 
The LIB project was a pre-experimental study (one group pre-test and post-test 
study). Non-clinical and clinical data were obtained from the LIB intensive lifestyle 
intervention pilot study. A secondary analysis was performed to answer the research 
question and hypotheses. 
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The LIB project was approved by the University of Nevada Las Vegas 
Institutional Review Board. All research activities were designed to have minimal risk to 
participants. Informed consent was required for all participants. 
Target Population 
The pilot study targeted urban AI/AN residents in Las Vegas, Nevada at increased 
risk for developing type 2 diabetes. Participants were recruited through community 
screenings, media announcements and referrals from other participants and/or project 
members. Six free community screenings were held at the Las Vegas Indian Center and 
Southern Nevada Native American Educational Coalition event in order to recruit 
qualified participants. The criteria for “increased risk” were defined as being overweight 
or obese and a glycosylated hemoglobin (HbA1c) level between 5.4% and 6.4% via a 
finger stick blood draw. Participants who met the inclusion criteria were informed about 
the LIB study and those who agreed to participate in would receive a 16-week core 
curriculum and regular follow-up. 
Inclusion Criteria 
1. Age 21 and older 
2. Self-identified AI/AN ethnicity 
3. Body mass index (BMI) ≥ 25 kg/m2  
4. HbA1c between 5.4% and 6.4% 
The LIB program was optimized and individualized for adult AI/ANs at high risk 
for type 2 diabetes. The presence of a BMI of 25 kg/m
2
 and above (overweight) and a 
glycosylated hemoglobin level between 5.4% and 6.4% diagnosis were essential risk 
factors identifying high-risk potential participants for the study. 
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Exclusion Criteria 
1. Major illness, myocardial infarction, symptoms of coronary heart disease, previous 
diabetes diagnosis, and pregnancy 
2. Use of medication improving glucose tolerance (e.g., metformin) 
3. Use of medication impairing glucose tolerance 
 The LIB program involved intensive lifestyle intervention which might be 
harmful for individuals with major illness or compromised health conditions. Individuals 
with previous diabetes diagnosis were excluded because the LIB program was designed 
to prevent the development of diabetes. Individuals using medications interfering glucose 
tolerance were excluded to avoid introducing a major confounding factor in this study.   
Non-Clinical and Clinical Measures 
Non-clinical data were obtained before and after the completion of the LIB 
lifestyle core curriculum. A baseline survey and a post-participation survey were 
conducted by lifestyle coaches. 
Clinical measures were collected at three different points in time before and after 
the completion of the LIB lifestyle core curriculum and the end of post-program follow-
up. All clinical procedures were followed standardized protocols and performed by 
trained clinical specialists. Clinical measures of interest included weight, waist 
circumference, blood pressure, triglycerides, HDL cholesterol, and fasting blood glucose. 
Data Security 
All survey data were secured with locked file cabinets and password protected 
computers at the American Indian Research and Education Center at University of 
Nevada Las Vegas. Biological samples were immediately analyzed and promptly 
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disposed afterward. All clinical data were stored in a secure digital database with 
restricted access. Each participant was assigned a unique identification number which 
disconnects the link between research data and participants’ identifiable information.  All 
participants’ identifiable information was accessible to senior research team members 
only. Each member of the research team was required to complete the Collaborative 
Institutional Training Initiative (CITI) Human Subjects Protections training prior to 
conducting research activities with the LIB program. The principal investigator was 
responsible for supervising all data collection activities. 
Data Management 
All question choices and responses were numbered by different coding formats 
for further statistical analysis. Non-clinical and clinical data were compiled into 
Microsoft Excel spreadsheets. A data codebook was developed to code and decode data. 
Data cleaning, recoding, and statistical analysis were performed after the completion of 
data collection.  
 
Statistical Methods 
This study was a pilot study with a small sample size (n=22). Considering the 
magnitude of attrition rates (31.8% and 45.5% at the completion of the core curriculum 
and follow-up respectively), two separate group analyses were conducted for each test. 
The first one was to analyze only the participants who completed the entire LIB program. 
The second one was to analyze all the participants including those who dropped out 
before completing the program by employing a simple intention-to treat analysis (last 
observation carry-forward analysis). The purpose of the intention-to-treat analysis is to 
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avoid the effects of a high drop-out rate because it is reported that participants who 
completed a program are more likely to show expected change than those who dropped 
out, hence skewing the results towards positive outcomes. The results from the two 
analyses were reported independently and a comparison was done to reveal whether the 
positive change was a potential result from intervention. Variables of interest are 
summarized in Table 1. 
 
Table 1. Variables of Interest 
Variables Type Range Values / Clinical Cut-off Values 
Sex Categorical 0 / 1 
0 = Male 
1 = Female 
Age (years) Continuous   
Education (%) Categorical 0 / 1 
0 = Without bachelor degree  
1 = Bachelor degree or higher  
Employment (%) Categorical 0 / 1 
0 = Unemployed 
1 = Employed 
Household income (%) Categorical 0 / 1 
0 = Less than $ 50,000 per year 
1 = 50,000 or greater per year 
Weight (kg) Continuous   
Waist circumference (cm) Continuous  102 in men, 88 in women 
Systolic blood pressure (mmHg) Continuous  130 
Diastolic blood pressure (mmHg) Continuous  85 
Triglycerides (mg/dL) Continuous  150 
HDL cholesterol (mg/dL) Continuous  40 in men, 50 in women 
Fasting blood glucose (mg/dL) Continuous  100 
Metabolic syndrome index Categorical 0 - 5  
 
The SPSS statistical package (SPSS 19, IBM, Armonk, NY) was used for data 
analysis. All statistical tests were two-tailed. The overall statistical significance level was 
set to α = 0.05. 
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Descriptive statistics was used to summarize the data. Mean, median and standard 
deviation were used to describe the central tendency and the dispersion for the variables 
of interest. 
Both the histogram and Kolmogorov-Smirnov test indicated that the pilot data 
violated the normal distribution assumption, which cannot be corrected by data 
transformation. Therefore, nonparametric methods were employed in the data analysis. 
The Wilcoxon signed-rank test and the Fisher’s exact test were used to compare 
the differences of demographic information and baseline clinical measures between 
participants who completed the program and those who dropped out.  
Hypothesis 1 and 3: The Friedman test was used to analyze the change of the 
variables of interest across the three time points. Post hoc analysis with Wilcoxon signed-
rank tests was conducted with a Bonferroni correction applied, resulting in a significance 
level set at p < 0.0167. Intention-to-treat analysis was applied in this step. 
Hypothesis 2: The Spearman's rank correlation coefficient was used to analyze the 
correlation between the components of metabolic syndrome and weight. Intention-to-treat 
analysis was applied in this step. 
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CHAPTER 4 
RESULTS 
 
A total of 22 (age, 39.6 ± 10.4 years; BMI, 34.1± 6.3 kg/m
2
) subjects were 
enrolled in this pilot study, 17 (77.3%) of them were female. Ten participants dropped 
out of the program before completion (dropout rate: 45.5%). The demographic 
information and baseline clinical data are summarized in Table 2. Based on subjects’ 
characteristics at entry there were no significant differences in demographic information 
and clinical measures between those participants who completed the program and those 
who dropped out of the program.  
 
Table 2. Demographic Characteristics and Baseline Clinical Measures of the Study Population 
Variables 
Participants who completed 
the program (n=12) 
Participants who dropped 
out (n=10) 
p-value 
Female (%) 83.33 70.00 0.624 
Age (years) 38.58 ± 9.55 40.70 ± 11.81 0.923 
Education (%)   0.074 
    Without bachelor degree 50.00 90.00  
    Bachelor degree or higher 50.00 10.00  
Employment (%)   0.293 
    Unemployed 8.33 30.00  
    Employed 91.67 70.00  
Household income (%)   1.000 
    < $ 50,000 66.70 70.00  
    ≥ $ 50,000 33.30 30.00  
Weight (kg) 96.67 ± 12.50 94.63 ± 28.64 0.381 
Waist circumference (cm) 110.89 ± 11.40 113.00 ± 21.64 0.974 
Triglycerides (mg/dL) 189.92 ± 109.41 152.10 ± 47.10 0.539 
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HDL cholesterol (mg/dL) 49.91 ± 15.42 48.00 ± 7.17 0.863 
Fasting blood glucose (mg/dL) 107.17 ± 10.26 107.50 ± 6.40 0.923 
Systolic BP (mmHg) 121.03 ± 14.49 116.99 ± 11.81 0.628 
Diastolic BP (mmHg) 78.07 ± 11.08 74.70 ± 8.04 0.418 
a. Values shown are mean values ± standard deviation (SD). 
b. Results are based on the Wilcoxon signed-rank test and the Fisher’s exact test. 
 
After the LIB intensive lifestyle intervention, 12 completers demonstrated a 
statistically significant drop in weight (5.79%, p=0.01) with a range of -2.82% to 14.23%, 
in spite of the fact that two-thirds of them did not achieve the goal of a 7% weight loss. 
Metabolic syndrome symptoms were improved to different extents at completion. Of the 
five components, only waist circumference and HDL cholesterol demonstrated 
statistically significant improvements (5.79%, p=0.01 and 12.92% p=0.007). Waist 
circumference decreased steadily across the three time points, but HDL cholesterol did 
not start to rise until completing the core curriculum. Triglycerides had the largest 
reduction (15.89%), but the change was not statistically significant and with high 
variability. Systolic blood pressure decreased more than diastolic blood pressure. Fasting 
blood glucose showed very limited improvement after the program (Table 3.1 & 3.2). 
 
Table 3.1. Comparison of Three Clinical Measures (n=12)  
Variables Baseline (1st) 
Completed core 
curriculum (2nd) 
Follow up (3rd) p-value Change 
Weight (kg) 96.67± 12.50 93.53 ± 12.44 91.07 ± 10.37 0.010* - 5.79% 
Waist circumference (cm) 110.89 ± 11.40 108.20 ± 11.66 106.08 ± 11.09 0.010* - 4.34% 
Triglycerides (mg/dL) 189.92 ± 109.41 158.42 ± 75.30 159.75 ± 72.14 0.717 - 15.89% 
HDL cholesterol (mg/dL) 49.91 ± 15.42 48.64 ± 15.00 56.36 ± 14.62 0.007* + 12.92% 
Fasting glucose (mg/dL) 107.17 ± 10.26 105.17 ± 7.94 106.75 ± 4.90 0.502 - 0.39% 
Systolic BP (mmHg) 121.03 ± 14.49 117.00 ± 10.26 113.72 ± 10.25 0.338 - 6.04% 
Diastolic BP (mmHg) 78.07 ± 11.08 78.71 ± 12.02 76.55 ± 11.82 0.779 - 1.95% 
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Table 3.2. Post Hoc Tests 
Variables 1st vs. 2nd 1st vs. 3rd 2nd vs. 3rd 
Weight (kg) 1st > 2nd, p = 0.003 1st > 3rd, p = 0.012 2nd = 3rd, p = 0.347 
Waist circumference (cm) 1st > 2nd, p = 0.016 1st = 3rd, p = 0.050 2nd = 3rd, p = 0.230 
HDL cholesterol (mg/dL) 1st = 2nd, p = 0.212 1st = 3rd, p = 0.045 2nd < 3rd, p = 0.004 
 
a. 1st refers to the first clinical measure before the LIB program; 2nd refers to the second clinical measure at 
the completion of the LIB core curriculum; 3rd refers to the third clinical measure at the end of follow-up. 
b. This procedure only included participants completing all three clinical measurements (n=12). 
c. Values shown are mean values ± standard deviation (SD). 
d. Results are based on the Friedman test. 
e. Post hoc results are based on the Wilcoxon signed-rank test with a Bonferroni correction (p < 0.0167); 
insignificant results are reported as equality, and no post hoc analysis was done. 
f. * indicates significant at 0.05. 
 
The results from the intention-to-treat analysis were highly consistent with those 
from the original analysis (Table 4.1 & 4.2), indicating that positive findings did not 
result from removing the data of drop-outs. However, the results from the intention-to-
treat analysis are not considered in the final results due to the risk of introducing bias and 
inflating type I error. 
 
Table 4.1. Comparison of Three Clinical Measures with Intention-to-treat Analysis (n=22)   
Variables Baseline (1st) 
Completed core 
curriculum (2nd) 
Follow up (3rd) p-value Change 
Weight (kg) 95.74 ± 20.84 93.87 ± 20.90 92.53 ± 20.36 0.008* - 3.35% 
Waist circumference (cm) 111.85 ± 16.43 109.95 ±16.96 108.79 ± 16.92 0.001* - 2.74% 
Triglycerides (mg/dL) 172.73 ± 87.14 151.18 ± 61.34 151.91 ± 59.41 0.581 - 12.05% 
HDL cholesterol (mg/dL) 49.00 ± 11.67 48.91 ± 11.58 52.91 ± 11.89 0.002* + 7.98% 
Fasting glucose (mg/dL) 107.32 ± 8.53 105.86 ± 6.98 106.73 ± 5.26 0.382 - 0.55% 
Systolic BP (mmHg) 119.19 ± 13.19 115.46 ± 11.64 113.67 ± 11.51 0.245 - 4.63% 
Diastolic BP (mmHg) 76.54 ± 9.74 75.71 ± 10.76 74.53 ± 10.35 0.368 - 2.63% 
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Table 4.2. Post Hoc Tests with Intention-to-treat Analysis (n=22) 
Variables 1st vs. 2nd 1st vs. 3rd 2nd vs. 3rd 
Weight (kg) 1st > 2nd, p = 0.005 1st > 3rd, p = 0.013 2nd = 3rd, p = 0.347 
Waist circumference (cm) 1st > 2nd, p = 0.004 1st > 3rd, p = 0.013 2nd = 3rd, p = 0.230 
HDL cholesterol (mg/dL) 1st = 2nd, p = 0.723 1st < 3rd, p = 0.010 2nd < 3rd, p = 0.004 
 
a. 1st refers to the first clinical measure before the LIB program; 2nd refers to the second clinical measure at 
the completion of the LIB core curriculum; 3rd refers to the third clinical measure at the end of follow-up. 
b. This procedure included all the participants (n=22). 
c. Values shown are mean values ± standard deviation (SD). 
d. Results are based on the Friedman test. 
e. Post hoc results are based on the Wilcoxon signed-rank test with a Bonferroni correction (p < 0.0167); 
insignificant results are reported as equality, and no post hoc analysis was done. 
f. * indicates significant at 0.05. 
 
In the correlation analysis, a significant correlation between waist circumference 
and weight was detected, which is in line with the anticipated result. No other metabolic 
syndrome components were correlated to weight (Table 5). 
 
Table 5. Correlation between Weight and Metabolic Syndrome Components (n=22) 
 
Waist 
circumference 
Triglycerides 
HDL 
cholesterol 
Fasting 
glucose 
Systolic BP Diastolic BP 
Weight        
      Rho 0.733* - 0.032 - 0.188 0.276 0.214 0.204 
      p-value <0.001 0.825 0.201 0.055 0.139 0.160 
 
a. This procedure included all the participants (n=22) with censored data. 
b. Results are based on the Spearman’s rank correlation coefficient. 
c. * indicates significant at 0.05. 
 
The metabolic syndrome index had an 11% drop in total score for the participants 
completing the LIB program, which was not statistically significant. The decrease was 
not evident until the completion of the core curriculum (Table 6). 
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Table 6. Comparison of Three Metabolic Syndrome Index Measures (n=12) 
Variables Baseline (1st) 
Completed core 
curriculum (2nd) 
Follow up (3rd) p-value Change 
Metabolic Syndrome Index 3.00 ± 1.41 3.00 ± 1.35 2.67 ± 0.99 0.256 - 11.00% 
 
a. 1st refers to the first clinical measure before the LIB program; 2nd refers to the second clinical measure at 
the completion of the LIB core curriculum; 3rd refers to the third clinical measure at the end of follow-up. 
b. This procedure only included participants completing all three clinical measurements (n=12). 
c. Values shown are mean values ± standard deviation (SD). 
d. Results are based on the Friedman test.  
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CHAPTER 5 
DISCUSSION, LIMITATIONS, AND CONCLUSIONS 
 
Discussion 
A weight loss of 7% of initial body weight was set as the primary study goal for 
the LIB program, because it is deemed to be safe, effective, and feasible for participants 
to maintain over a long-term follow-up. Unfortunately, weight loss data failed to 
demonstrate the efficacy of the LIB program in minimizing the risk for diabetes because 
the 12 participants completing the program had an average weight loss of 5.79% at 
completion. Weight loss alone, however, cannot quantify the magnitude of risk reduction 
for diabetes and its complications. A metabolic syndrome index introduced a novel 
approach and an informative framework from which to evaluate LIB program outcomes. 
In the present study a significant correlation was found between weight and waist 
circumference across the program spectrum. Weight and waist circumference are 
universal parameters in estimating general and abdominal obesity respectively. Abnormal 
body fat distribution, particularly around abdomen, is highly associated with an increased 
risk for diabetes, even if the BMI falls within the normal range (Schulze et al., 2006). A 
German research team pointed out that waist circumference gives a better prediction of 
diabetes risk than BMI because development of diabetes is influenced more by visceral 
fat tissue which is metabolically more active and produces more hormones and cytokines, 
and this relationship is more pronounced in people with normal BMI (Feller, Boeing, & 
Pischon, 2010).  Statistically speaking, weight might be an inferior alternative to waist 
circumference (r = 0.733, p < 0.001), but it cannot take over the roles of other metabolic 
risk factors, which was evidenced by the non-significant correlation between weight and 
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triglycerides, HDL cholesterol, fasting glucose and blood pressure seen in the present 
study. Obesity plays a role in hyperinsulinemia, insulin resistance, dyslipidemia, and 
hypertension. However, the pathogenetic interactions do not allow obesity to serve a 
substitute for the other metabolic syndrome components. This inference is supported by 
the high prevalence of metabolic syndrome among individuals with normal to slightly 
elevated BMI (St-Onge, Janssen, & Heymsfield, 2004) and significant type 2 diabetes 
incidence reduction after lifestyle intervention with minimal weight loss (Tuomilehto et 
al., 2001). 
The metabolic risk for diabetes and its complications has a multifaceted structure 
comprising environmental and behavioral factors. Lifestyle intervention for diabetes 
prevention programs works on these facets simultaneously with complex health 
promotion strategies. A metabolic syndrome index acts as a systematic and 
comprehensive indicator in evaluating the efficacy of lifestyle interventions by targeting 
the five principal metabolic factors. The results of the current study indicated that the LIB 
lifestyle intervention succeeded in lowering the metabolic risk for diabetes and its 
complications by 11% among the small pilot population. Since metabolic risk is an 
estimate of a modifiable proportion of the risk for diabetes and its complications, this 
parameter is more pragmatic for public health professionals by separating from non-
modifiable risk like genetic predisposition or developmental metabolic programming. 
The value was higher than the percentage of weight loss, suggesting that a metabolic 
syndrome index covered more aspects of the risk for diabetes and its complications which 
cannot be revealed by weight alone.  
32 
 
The metabolic syndrome components responded differently to the LIB lifestyle 
intervention. Only waist circumference and HDL cholesterol demonstrated statistically 
significant improvement. Waist circumference manifested a significant correlation with 
weight. Both of them showed a significant reduction at the completion of the core 
curriculum, although this trend slowed down in the follow-up period. The core 
curriculum was the most structured phase of the LIB lifestyle intervention involving 
increased physical activity and decreased calorie and fat intake. All the participants were 
required to set individualized goals for weight loss and fat/calorie intake before the core 
curriculum and were encouraged to achieve these goals within 4 months. The early 
achievement of a significant reduction of waist circumference might be attributed to the 
presence of lifestyle coaches and an incentive package that included a free gym 
membership. With the guidance and supervision of the lifestyle coaches as well as 
accessible sports apparatus, participants were more prone to follow the scheduled 
exercise and diet plan. However, after removing extrinsic motivations, a self-managed 
and self-monitored plan was employed to reinforce the acquired positive behavioral 
changes in the follow-up period, which might have contributed to the deceleration of the 
waist circumference reduction. No weight and waist circumference regain occurred at the 
end of the follow-up period, indicating that the core curriculum was effective in helping 
participants master weight maintenance skills and the effect of the LIB lifestyle 
intervention persisted at least 35 weeks. Considering the efficiency of weight loss and 
waist circumference reduction seen during the core curriculum, an extension of the core 
curriculum may be helpful to achieve the original goal of a 7% weight loss.  
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HDL and triglycerides are two typical lipoproteins in diabetic dyslipidemia, 
although their responses to lifestyle interventions may differ. A 36-month clinical trial in 
Germany found that both diet alone and diet combined with exercise decreased 
triglyceride levels and increased HDL cholesterol values in participants with metabolic 
syndrome (Christ et al., 2004). Two similar studies in Italy and the United States found 
that no change occurred in HDL cholesterol from baseline after 5-month and 6-month 
lifestyle intervention respectively, regardless of a significant reduction in waist 
circumference and triglyceride levels (Muzio et al., 2007 & Rector et al., 2007). Results 
from the three studies suggest that triglycerides have a quick response to lifestyle 
intervention while HDL cholesterol demands a longer period to manifest observable 
positive change. In the present study, HDL cholesterol remained steady throughout the 
16-week core curriculum, but a statistically significant elevation was observed during the 
follow-up period. No significant change was detected in triglycerides, but these showed 
the highest percentage of decrease which mainly occurred during the core curriculum. 
These findings are in concordance with the assumption above, indicating that elevation of 
HDL cholesterol has a long lag time and a 16-week ongoing LIB lifestyle intervention is 
effective to increase HDL cholesterol in the long term. 
Many studies have indicated that hypertension can be relieved through lifestyle 
intervention, especially in decreasing systolic blood pressure (Christ et al., 2004, 
Meckling et al., 2007). A smaller decrease was observed in diastolic blood pressure 
compared with systolic blood pressure in the present study, but neither was statistically 
significant. One possible explanation is that the average baseline blood pressure among 
our participants was within normal range (systolic BP: 119.19 ± 13.19 mmHg; diastolic 
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BP: 76.54 ± 9.74 mmHg), which might have limited the effect of the LIB lifestyle 
intervention in alleviating hypertension. 
Hyperglycemia is one of the primary symptoms in individuals with prediabetes 
and diabetes. It is also the most intractable target in diabetes prevention programs. Diet 
and exercise are widely perceived to be beneficial for glycemic control. However, 
conflicting results on the effects of lifestyle intervention in improving hyperglycemia are 
common in clinical trials. In the present study, fasting blood glucose was not affected by 
the LIB lifestyle intervention. In addition, no sign of improvement in long-term glycemic 
control was observed, which was evidenced by stable glycosylated hemoglobin (HbA1c) 
levels (data not shown).  This finding is consistent with a recent study in an overweight 
and obese female Canadian population, reporting that fasting blood glucose was not 
affected by diet and exercise regardless of a significant weight loss (Meckling et al., 
2007). Moderate weight loss is beneficial in improving insulin resistance (Reaven, 2005). 
Previous studies have shown that a 10% weight loss lowers blood glucose and improves 
cardiovascular risk factors. It is possible that an average weight loss of less than 10% is 
not sufficient to trigger a detectable reduction of blood glucose. On the other hand, 
considerable evidence showed that isocaloric diet, low in fat and enriched in 
carbohydrates, will exacerbate insulin resistance. Replacing saturated fat with 
carbohydrates may increase daily blood glucose level because it requires more insulin to 
maintain glucose homoeostasis, which is demanding in individuals with insulin resistance 
(Reaven, 2005). The LIB core curriculum emphasizes reducing fat and total calorie intake 
without a structured guide for dietary macronutrient content. High levels of carbohydrate 
intake might have counteracted the effect of weight loss in improving insulin resistance 
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and lowering blood glucose. The addition of a structured dietary macronutrient content 
guide in the LIB core curriculum may be effective in achieving more weight loss and an 
observable fasting blood glucose reduction. 
In summary, the results indicate that the LIB program reduced the metabolic risk 
for diabetes and its complications by 11% in urban Native Americans living in Las Vegas 
with increased diabetes risk. The current LIB core curriculum is effective in decreasing 
waist circumference and elevating HDL cholesterol level.  Further research is needed to 
investigate the effect of an extended and optimized core curriculum in strengthening the 
efficacy of the LIB program.  
 
Limitations 
Some limitations of this study have to be taken into account. First, this pilot study 
has a small sample size. Even the intention-to-treat analysis indicates that the positive 
changes may be attributable to the lifestyle intervention itself, but large variability 
resulting from a small sample size may mask some significant results. Second, the last 
follow-up visit was completed at either 8 months or 12 months after the first clinical 
measure, resulting in a follow-up period varied from 8.1 months to 12.8 months. 
Theoretically acquired positive behaviors gradually weaken over time without proper 
reinforcement. Participants who had an early follow-up visit might behave better than 
those who had a late follow-up visit, which might have influenced the last clinical 
measure. Third, due to the nature of secondary analysis, some important confounding 
factors cannot be included in this study. Social support is crucial in shaping and 
consolidating individuals’ positive behaviors. Information like marital status was not 
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collected in the LIB pilot study, which might also contribute to a high dropout rate. 
Information on lifestyle choices like smoking and drinking was not collected as well, 
which play a role in increasing metabolic risk related to diabetes, which might have 
attenuated the effects of the LIB program. 
 
Conclusions 
In conclusion, findings from the present study imply that the application of the 
metabolic syndrome index provides more detailed information in addition to weight in 
evaluating diabetes prevention program outcomes by analyzing pre-post changes in 
multiple diabetes markers, particularly when the target population has normal to slight 
elevated BMI. It also serves as comparison for other evaluation tools used in diabetes 
prevention programs by reporting the amount of metabolic risk for diabetes and its 
complications that has been reduced. Additionally, the changes in metabolic syndrome 
components outline the characteristics of diabetes prevention programs, showing great 
potential for helping public health professionals to individualize and optimize program 
curriculums for different target populations. Promotion of metabolic syndrome index in 
diabetes research will establish a unified criterion in evaluating diabetes prevention 
programs and facilitate efficacy comparison among different programs.  
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APPENDIX 1 
SUMMARY OF METABOLIC SYNDROME CRITERIA 
 
 
 
  
38 
 
BIBLIOGRAPHY 
 
Alberti, K. G., Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes 
mellitus and its complications, part 1: diagnosis and classification of diabetes 
mellitus provisional report of a WHO consultation. Diabetic Medicine, 15(7), 
539-553. 
Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome - a new 
worldwide definition. Lancet, 366(9491), 1059-1062. 
Ali, M. K., Echouffo-Tcheugui, J., & Williamson, D. F. (2012). How effective were 
lifestyle interventions in real-world settings that were modeled on the Diabetes 
Prevention Program? Health Affairs, 31(1), 67-75. 
American Diabetes Association. (2012). How to Tell if You Have Diabetes or 
Prediabetes. Retrieved from http://www.diabetes.org/diabetes-
basics/prevention/pre-diabetes/diagnosis.html 
Balkau, B. & Charles, M. A. (1999). Comment on the provisional report from the WHO 
consultation. European Group for the Study of Insulin Resistance (EGIR). 
Diabetic Medicine, 16(5), 442-443. 
Benyshek, D. C. (2001). A reconsideration of the origins of the type 2 diabetes epidemic 
among Native Americans and the implications for intervention policy. Medical 
Anthropology, 20(1), 25-64. 
Benyshek, D. C. (2007). The developmental origins of obesity and related health 
disorders: Prenatal and perinatal factors. Collegium Antropologicum, 31(1), 315-
321. 
Caprio, S., Daniels, S. R., Drewnowski, A., Kaufman, F. R., Palinkas, L. A., 
39 
 
Rosenbloom, A. L., & Schwimmer, J. B. (2008). Influence of race, ethnicity, and 
culture on childhood obesity: implications for prevention and treatment: a 
consensus statement of Shaping America's Health and the Obesity Society. 
Diabetes Care, 31(11), 2211-2221. 
Centers for Disease Control and Prevention. (2003). Leading Causes of Death. Retrieved 
from http://www.cdc.gov/nchs/fastats/lcod.htm 
Centers for Disease Control and Prevention. (2011). 2011 National Diabetes Fact Sheet. 
Retrieved from http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf 
Centers for Disease Control and Prevention. (2009). Diabetes Prevalence Among 
American Indians and Alaska Natives and the Overall Population. Retrieved from 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5230a3.htm 
Christ, M., Iannello, C., Iannello, P. G., & Grimm, W. (2004). Effects of a weight 
reduction program with and without aerobic exercise in the metabolic syndrome. 
International Journal of Cardiology, 97(1), 115-122. 
Dall, T. M., Zhang, Y., Chen, Y. J., Quick, W. W., Yang, W. G., & Fogli, J. (2010). The 
economic burden of diabetes. Health Affairs, 29(2), 297-303.  
Deen, D. (2004). Metabolic syndrome: Time for action. American Family Physician, 
69(12), 2875-2882. 
Diabetes Prevention Program Research Group. (2002). The Diabetes Prevention Program 
(DPP): Description of lifestyle intervention. Diabetes Care, 25(12), 2165-2171. 
Feller, S., Boeing, H., & Pischon, T. (2010). Body mass index, waist circumference, and 
the risk of type 2 diabetes mellitus: implications for routine clinical practice. 
Deutsches Ärzteblatt International, 107(26), 470-476. 
40 
 
Ford, E. S., Li, C., & Sattar, N. (2008). Metabolic syndrome and incident diabetes: 
current state of the evidence. Diabetes Care, 31(9), 1898-1904. 
Grundy, S. M., Brewer, B. H., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004). 
Definition of metabolic syndrome, report of the National Heart, Lung, and Blood 
Institute/American Heart Association Conference on Scientific Issues Related to 
Definition. Circulation, 109(3), 433-438. 
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. 
A., & Gordon, D. J. (2005). Diagnosis and management of the metabolic 
syndrome, an American Heart Association/National Heart, Lung, and Blood 
Institute Scientific Statement. Critical Pathways in Cardiology, 4(4), 198-203. 
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L. 
D., & Hoskin, A. M. (2006). Effect of weight loss with lifestyle intervention on 
risk of diabetes. Diabetes Care, 29(9), 2102-2107. 
Kelley, D. E., & Goodpaster, B. H. (2001). Effects of exercise on glucose homeostasis in 
Type 2 diabetes mellitus. Medcine and Science in Sports and Exercise, 33(6), 
S495-S501. [Discussion in S528-S529] 
Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., 
Walker, E. A., & Nathan, D. M. (2007). Reduction in the incidence of type 2 
diabetes with lifestyle intervention or metformin. New England Journal of 
Medicine, 346(6), 393-403. 
Knowler, W. C., Fowler, S. E., Hamman, R. F., Christophi, C. A., Hoffman, H. J., & 
Brenneman, A. T. (2009). 10-year follow-up of diabetes incidence and weight 
loss in the Diabetes Prevention Program Outcomes Study. Lancet, 374(9712), 
41 
 
1677-1686. 
Lakka, T. A., Rankinen, T., Weisnagel, S. J., Chagnon, Y. C., Lakka, H. M., Ukkola, O., 
& Boulé, N. (2004). Leptin and leptin receptor gene polymorphisms and changes 
in glucose homeostasis in response to regular exercise in nondiabetic individuals: 
the HERITAGE family study. Diabetes, 53(6), 1603-1608. 
Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., & Haffner, S. M. (2003). The 
metabolic syndrome as predictor of type 2 diabetes. Diabetes Care, 26(11), 3153-
3159. 
Mannucci, E., Monami, M., Cresci, B., Pala, L., Bardini, G., Petracca, M. G., & 
Dicembrini, I. (2008). National Cholesterol Education Program and International 
Diabetes Federation definitions of metabolic syndrome in the prediction of 
diabetes. Results from the FIrenze-Bagno A Ripoli study. Diabetes, Obesity and 
Metabolism, 10(5), 430-435. 
Meckling, K. A., & Sherfey, R. (2007). A randomized trial of a hypocaloric high-protein 
diet, with and without exercise, on weight loss, fitness, and markers of the 
Metabolic Syndrome in overweight and obese women. Applied Physiology, 
Nutrition, and Metabolism, 32(4), 743-752. 
Mokdad, A. H., Bowman, B. A., Enqelqau, M. M., & Vinicor F.  (2001). Diabetes trends 
among American Indians and Alaska natives: 1990-1998. Diabetes Care, 
24(8), 1508-1509. 
Moller, D. E., & Kaufman, K. D. (2005). Metabolic syndrome: A clinical and molecular 
perspective. Annual Review of Medicine, 56, 45-62. 
Muzio, F., Mondazzi, L., Harris, W. S., Sommariva, D., & Branchi, A. (2007). Effects of 
42 
 
moderate variations in the macronutrient content of the diet on cardiovascular 
disease risk factors in obese patients with the metabolic syndrome. The American 
Journal of Clinical Nutrition, 86(4), 946-951. 
National Diabetes Education Program. (2012). Diabetes Risk Factors. Retrieved from 
http://ndep.nih.gov/am-i-at-risk/DiabetesRiskFactors.aspx 
Neel, J. V. (1962). Diabetes Mellitus: A “Thrifty” genotype rendered detrimental by 
“progress”. American Journal of Human Genetics, 57, 353-362.  
Neel, J. V. (1999). The "thrifty genotype" in 1998. Nutrition Reviews, 57(5), Part2, S2-
S9.  
Orchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., & 
Fowler, S. (2005). The effect of metformin and intensive lifestyle intervention on 
the metabolic syndrome: the Diabetes Prevention Program randomized trial. 
Annuals of Internal Medicine, 142(8), 611-619. 
Okura, T., Nakata, Y., Ohkawara, K., Numao, S., Katayama, Y., Matsuo, T., & Tanaka, 
K. (2007). Effects of aerobic exercise on metabolic syndrome improvement in 
response to weight reduction. Obesity, 15(10), 2478-2484.  
Pan, X. R., Li, G. W., Hu, Y. H., Wang, J. X., Yang, W. Y., An, Z. X., & Hu, Z. X. 
(1997). Effects of diet and exercise in preventing NIDDM in people with 
impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 
20(4), 537-544. 
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., & Vijay, V. 
(2006). The Indian Diabetes Prevention Programme shows that lifestyle 
modification and metformin prevent type 2 diabetes in Asian Indian subjects with 
43 
 
impaired glucose tolerance (IDPP-1). Diabetologia, 49(2), 289-297. 
Reaven, G. M. (1988). Banting lecture 1988: role of insulin resistance in human disease. 
Diabetes, 37(12), 1595-1607. 
Reaven, G. M. (2005). The insulin resistance syndrome: definition and dietary 
approaches to treatment. Annual Review of Nutrition, 25, 391-406. 
Rector, R. S., Warner, S. O., Liu, Y., Hinton, P. S., Sun, G. Y., Cox, R. H., & Stump, C. 
S. (2007). Exercise and diet induced weight loss improves measures of oxidative 
stress and insulin sensitivity in adults with characteristics of the metabolic 
syndrome. American Journal of Physiology. Endocrinal Metabolism, 293(2), 
E500-E506. 
Ritenbaugh, C., & Goodby, C. S. (1989). Beyond the thrifty gene: metabolic implications 
of prehistoric migration into the New World. Medical Anthropology, 11(3), 227-
236. 
Ross, R., Dagnone, D., Jones, P. J., Smith, H., Paddags, A., Hudson, R., & Janssen, I. 
(2000). Reduction in obesity and related comorbid conditions after diet-induced 
weight loss or exercise-induced weight loss in men. A randomized, controlled 
trial. Annals of Internal Medicine, 133(2), 92-103. 
Schulze, M. B., Heidemann, C., Schienkiewitz, A., Bergmann, M. M., Hoffmann, K., & Boeing, 
H. (2006). Comparison of anthropometric characteristics in predicting the incidence of 
type 2 diabetes in the EPIC-Potsdam study. Diabetes Care, 29(8), 1921-1923. 
Shaw, D. I., Hall, W. L., & Williams, C. M. (2005). Metabolic syndrome: what is it and 
what are the implications? The Proceedings of the Nutrition Society, 64(3), 349-
357. 
Stern, M. P. (1995). Diabetes and cardiovascular disease. The "common soil" 
44 
 
hypothesis. Diabetes, 44(4), 369-374. 
St-Onge, M. P., Janssen, I., & Heymsfield, S. B. (2004). Metabolic syndrome in normal-
weight Americans: new definition of the metabolically obese, normal-weight 
individual. Diabetes Care, 27(9), 2222-2228. 
The expert committee on the diagnosis and classification of diabetes mellitus. (2003). 
Report of the Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus. Diabetes Care, 26, S5-S20. 
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-
Parikka, P., & Keinänen-Kiukaanniemi, S. (2001). Prevention of type 2 diabetes 
mellitus by changes in lifestyle among subjects with impaired glucose tolerance. 
The New England Journal of Medicine, 344(18), 1343-1350. 
Valway, S., Freeman, W., Kaufman, S., Welty, T., Helgerson, S. D., & Gohdes, D. 
(1993). Prevalence of diagnosed diabetes among American Indians and Alaska 
Natives, 1987. Estimates from a national outpatient data base. Diabetes Care, 
16(1), 271-276. 
Wassink, A. M., Van Der Graaf, Y., Soedamah-Muthu, S. S., Spiering, W., & Visseren, 
F. L. (2008). Metabolic syndrome and incidence of type 2 diabetes in patients 
with manifest vascular disease. Diabetes and Vascular Disease Research, 5(2), 
114-122. 
World Health Organization. (2012). About the Diabetes Programme. Retrieved from 
http://www.who.int/diabetes/goal/en/index.html 
World Health Organization. (2008). The top 10 causes of death. Retrieved from 
http://www.who.int/mediacentre/factsheets/fs310/en/index.html 
45 
 
Wilson, P. W. F., D’Agostino, R. B., Parise, H., Sullivan, L., & Meigs, J. B. (2005). 
Metabolic syndrome as a precursor of cardiovascular disease and type 2 
diabetes. Circulation, 112(20), 3066-3072. 
 
46 
 
VITA 
 
Graduate College 
University of Nevada, Las Vegas 
 
Hongbin Jin 
 
Degree: 
Bachelor of Science, Nursing, 2006 
Shanghai Jiao Tong University, China 
 
Special Honors and Awards: 
UNLV Access Grant - Grad NN, Spring 2011, Fall 2011 & Spring 2012 
UNLV James F. Adams/GPSA Scholarship, Fall 2011 & Spring 2012 
Member of UNLV Honor Society of Phi Kappa Phi, April 2012 - Current  
 
Thesis Title: Utilization of a Metabolic Syndrome Index in Evaluating Life in 
BALANCE Lifestyle Intervention for Prevention of Type 2 Diabetes among 
Urban American Indians and Alaska Natives 
 
Thesis Examination Committee: 
Chairperson, Michelle Chino, PhD 
Committee Member, Sheniz Moonie, PhD 
Committee Member, Timothy Bungum, DrPH 
Graduate Faculty Representative, Daniel Benyshek, PhD  
 
 
 
 
 
 
 
 
 
 
 
